# EDGAR Filing Document

**Accession Number:** 0000059478
**File Stem:** 0001193125-26-209416
**Filing Date:** 2026-5
**Character Count:** 20642
**Document Hash:** fa13857ea928bb8ea18cd8c0b0d8f0a6
**Contains OCR:** False
**Source Format:** 

## Filing Content

## Filing Summary
**0001193125-26-209416.hdr.sgml**: 20260506

**ACCESSION NUMBER**: 0001193125-26-209416

**CONFORMED SUBMISSION TYPE**: FWP

**PUBLIC DOCUMENT COUNT**: 2

**FILED AS OF DATE**: 20260506

**DATE AS OF CHANGE**: 20260506

**SUBJECT COMPANY**: 

**COMPANY DATA:**
- **COMPANY CONFORMED NAME:** ELI LILLY & Co
- **CENTRAL INDEX KEY:** 0000059478
- **STANDARD INDUSTRIAL CLASSIFICATION:** PHARMACEUTICAL PREPARATIONS [2834]
- **ORGANIZATION NAME:** 03 Life Sciences
- **EIN:** 350470950
- **STATE OF INCORPORATION:** IN
- **FISCAL YEAR END:** 1231

**FILING VALUES:**
- **FORM TYPE:** FWP
- **SEC ACT:** 1934 Act
- **SEC FILE NUMBER:** 333-285052
- **FILM NUMBER:** 26949830

**BUSINESS ADDRESS:**
- **STREET 1:** LILLY CORPORATE CTR
- **STREET 2:** DROP CODE 1094
- **CITY:** INDIANAPOLIS
- **STATE:** IN
- **ZIP:** 46285
- **BUSINESS PHONE:** 3172762000

**MAIL ADDRESS:**
- **STREET 1:** LILLY CORPORATE CENTER
- **STREET 2:** DROP CODE 1094
- **CITY:** INDIANAPOLIS
- **STATE:** IN
- **ZIP:** 46285

**FORMER COMPANY:**
- **FORMER CONFORMED NAME:** LILLY ELI & CO
- **DATE OF NAME CHANGE:** 19941024
**FILED BY**: 

**COMPANY DATA:**
- **COMPANY CONFORMED NAME:** ELI LILLY & Co
- **CENTRAL INDEX KEY:** 0000059478
- **STANDARD INDUSTRIAL CLASSIFICATION:** PHARMACEUTICAL PREPARATIONS [2834]
- **ORGANIZATION NAME:** 03 Life Sciences
- **EIN:** 350470950
- **STATE OF INCORPORATION:** IN
- **FISCAL YEAR END:** 1231

**FILING VALUES:**
- **FORM TYPE:** FWP

**BUSINESS ADDRESS:**
- **STREET 1:** LILLY CORPORATE CTR
- **STREET 2:** DROP CODE 1094
- **CITY:** INDIANAPOLIS
- **STATE:** IN
- **ZIP:** 46285
- **BUSINESS PHONE:** 3172762000

**MAIL ADDRESS:**
- **STREET 1:** LILLY CORPORATE CENTER
- **STREET 2:** DROP CODE 1094
- **CITY:** INDIANAPOLIS
- **STATE:** IN
- **ZIP:** 46285

**FORMER COMPANY:**
- **FORMER CONFORMED NAME:** LILLY ELI & CO
- **DATE OF NAME CHANGE:** 19941024

**Free Writing Prospectus** 

**Filed Pursuant to Rule 433** 

**Registration Statement No. 333-285052** 

**Dated May 6, 2026**![LOGO](g110421g0507021825308.jpg)

**Eli Lilly and Company** 

**Pricing Term Sheet** 

$9,000,000,000 aggregate principal amount of Notes offered, consisting of:

Floating Rate Notes due 2028 (the "2028 Floating Rate Notes")

Floating Rate Notes due 2029 (the "2029 Floating Rate Notes")

4.150% Notes due 2029 (the "2029 Notes")

4.375% Notes due 2031 (the "2031 Notes")

4.650% Notes due 2033 (the "2033 Notes")

4.850% Notes due 2036 (the "2036 Notes")

5.600% Notes due 2056 (the "2056 Notes")

5.700% Notes due 2066 (the "2066 Notes")

(The 2028 Floating Rate Notes and the 2029 Floating Rate Notes are collectively referred to as the "Floating Rate Notes." The 2029 Notes, the 2031 Notes, the 2033 Notes, the 2036 Notes, the 2056 Notes and the 2066 Notes are collectively referred to as the "Fixed Rate Notes." The Fixed Rate Notes, together with the Floating Rate Notes, are collectively referred to as the "Notes")

This pricing term sheet (the "Pricing Term Sheet") supplements the prospectus supplement issued by Eli Lilly and Company on May 6, 2026 (the "Preliminary Prospectus Supplement") and the accompanying prospectus dated February 19, 2025 (the "Prospectus") and supersedes the information in the Preliminary Prospectus Supplement and Prospectus. Other information presented in the Preliminary Prospectus Supplement is deemed to have changed to the extent affected by the changes described herein. Otherwise, this Pricing Term Sheet is qualified in its entirety by reference to the Preliminary Prospectus Supplement and the Prospectus and should be read together with the Preliminary Prospectus Supplement, the Prospectus and the documents incorporated or deemed to be incorporated by reference therein before a decision is made to invest in the Notes.

---

| | |
|:---|:---|
| Issuer: | Eli Lilly and Company |
| Trade Date: | May 6, 2026 |
| Ratings:\* | Aa3 (Positive) Moody's<br> AA- (Positive) S&P |
| Settlement Date:\*\* | May 20, 2026; T+10 |
| Day Count Convention: | Actual / 360 for the Floating Rate Notes<br> 30 / 360 for the Fixed Rate Notes |
| Joint Book-Running Managers: | Morgan Stanley & Co. LLC<br> Citigroup Global Markets Inc.<br> Deutsche Bank Securities Inc.<br> Goldman Sachs & Co. LLC <br>BNP Paribas Securities Corp. <br>J.P. Morgan Securities LLC <br>BofA Securities, Inc. <br>Barclays Capital Inc. <br>Mizuho Securities USA LLC <br>|

---

------

---

| | |
|:---|:---|
| Co-Managers: | Loop Capital Markets LLC <br>Penserra Securities LLC |
| **<u>The 2028 Floating Rate Notes</u>** |  |
| Principal Amount Offered: | $750000000 |
| Maturity Date: | May 20, 2028 |
| Public Offering Price: | 100.000% of principal amount, plus accrued interest, if any, from May 20, 2026 |
| Interest Rate Basis: | Compounded SOFR |
| Spread to Compounded SOFR: | +35 basis points |
| Interest Payment Dates: | February 20, May 20, August 20 and November 20 of each year, commencing August 20, 2026 |
| Interest Reset Dates: | Each Floating Rate Interest Payment Date |
| Initial Interest Rate: | The initial interest rate will be Compounded SOFR determined on August 18, 2026, plus 35 basis points |
| Interest Determination Date: | The second U.S. Government Securities Business Day preceding each Floating Rate Interest Payment Date |
| Interest Period: | The period from and including a Floating Rate Interest Payment Date to, but excluding, the immediately succeeding Floating Rate Interest Payment Date (such succeeding Floating Rate Interest Payment Date, the "Latter Floating Rate Interest Payment Date"); provided that (i) the initial interest period for the 2028 Floating Rate Notes will be the period from and including the Settlement Date to, but excluding, the immediately succeeding Floating Rate Interest Payment Date for the 2028 Floating Rate Notes and (ii) the final interest period for the 2028 Floating Rate Notes will be the period from and including the Floating Rate Interest Payment Date immediately preceding the maturity date of the 2028 Floating Rate Notes to, but excluding, the maturity date of the 2028 Floating Rate Notes |
| Observation Period: | The period from and including two U.S. Government Securities Business Days preceding the first date of such relevant Interest Period to but excluding two U.S. Government Securities Business Days preceding the Latter Floating Rate Interest Payment Date for such relevant Interest Period for the 2028 Floating Rate Notes; provided that the first Observation Period for the 2028 Floating Rate Notes shall be the period from and including two U.S. Government Securities Business Days preceding the Settlement Date to, but excluding, the two U.S. Government Securities Business Days preceding the first Floating Rate Interest Payment Date for the 2028 Floating Rate Notes |
| Redemption Provisions: | The 2028 Floating Rate Notes will not be redeemable prior to their maturity |
| Calculation Agent: | Initially, Deutsche Bank Trust Company Americas |
| CUSIP / ISIN: | 532457 DH8 / US532457DH81 |
| **<u>The 2029 Floating Rate Notes</u>** |  |
| Principal Amount Offered: | $500000000 |
| Maturity Date: | May 20, 2029 |

---

------

---

| | |
|:---|:---|
| Public Offering Price: | 100.000% of principal amount, plus accrued interest, if any, from May 20, 2026 |
| Interest Rate Basis: | Compounded SOFR |
| Spread to Compounded SOFR: | +46 basis points |
| Interest Payment Dates: | February 20, May 20, August 20 and November 20 of each year, commencing August 20, 2026 |
| Interest Reset Dates: | Each Floating Rate Interest Payment Date |
| Initial Interest Rate: | The initial interest rate will be Compounded SOFR determined on August 18, 2026, plus 46 basis points |
| Interest Determination Date: | The second U.S. Government Securities Business Day preceding each Floating Rate Interest Payment Date |
| Interest Period: | The period from and including a Floating Rate Interest Payment Date to, but excluding, the immediately succeeding Floating Rate Interest Payment Date (such succeeding Floating Rate Interest Payment Date, the "Latter Floating Rate Interest Payment Date"); provided that (i) the initial interest period for the 2029 Floating Rate Notes will be the period from and including the Settlement Date to, but excluding, the immediately succeeding Floating Rate Interest Payment Date for the 2029 Floating Rate Notes and (ii) the final interest period for the 2029 Floating Rate Notes will be the period from and including the Floating Rate Interest Payment Date immediately preceding the maturity date of the 2029 Floating Rate Notes to, but excluding, the maturity date of the 2029 Floating Rate Notes |
| Observation Period: | The period from and including two U.S. Government Securities Business Days preceding the first date of such relevant Interest Period to but excluding two U.S. Government Securities Business Days preceding the Latter Floating Rate Interest Payment Date for such relevant Interest Period for the 2029 Floating Rate Notes; provided that the first Observation Period shall for the 2029 Floating Rate Notes be the period from and including two U.S. Government Securities Business Days preceding the Settlement Date to, but excluding, the two U.S. Government Securities Business Days preceding the first Floating Rate Interest Payment Date for the 2029 Floating Rate Notes |
| Optional Redemption: | Subject to the special mandatory redemption provision described below, the Issuer may not redeem the 2029 Floating Rate Notes at its option prior to maturity |
| Special Mandatory Redemption: | In the event that (x) the Centessa Acquisition is not consummated on or prior to the date that is five (5) business days after the later of (i) March 31, 2027 or (ii) any later date as the parties to the Centessa Agreement may agree as the "Outside Date" thereunder or (y) the Issuer notifies the trustee in writing that the Issuer will not pursue the consummation of the Centessa Acquisition, the Issuer will be required to redeem the 2029 Floating Rate Notes then outstanding at a redemption price equal to 101% of the principal amount of such 2029 Floating Rate Notes plus accrued and unpaid interest, if any, to, but excluding, the Centessa Special Mandatory Redemption Date |
| Calculation Agent: | Initially, Deutsche Bank Trust Company Americas |
| CUSIP / ISIN: | 532457 DJ4 / US532457DJ48 |

---

------

---

| | |
|:---|:---|
| **<u>The 2029 Notes</u>** |  |
| Principal Amount Offered: | $750000000 |
| Maturity Date: | May 20, 2029 |
| Coupon: | 4.150% per year |
| Public Offering Price: | 99.941% of principal amount, plus accrued interest, if any, from May 20, 2026 |
| Yield to Maturity: | 4.171% |
| Benchmark Treasury: | UST 3.875% due April 15, 2029 |
| Spread to Benchmark Treasury: | T + 28 basis points |
| Benchmark Treasury Price and Yield: | 99-30+ / 3.891% |
| Interest Payment Dates: | May 20 and November 20 of each year, commencing November 20, 2026 |
| Redemption Provisions: |  |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Make-whole call: | At any time prior to April 20, 2029 at a discount rate of Treasury plus 5 basis points |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Par call: | On or after April 20, 2029 at 100% |
| Special Mandatory Redemption: | In the event that (x) the Centessa Acquisition is not consummated on or prior to the date that is five (5) business days after the later of (i) March 31, 2027 or (ii) any later date as the parties to the Centessa Agreement may agree as the "Outside Date" thereunder or (y) the Issuer notifies the trustee in writing that the Issuer will not pursue the consummation of the Centessa Acquisition, the Issuer will be required to redeem the 2029 Notes then outstanding at a redemption price equal to 101% of the principal amount of such 2029 Notes plus accrued and unpaid interest, if any, to, but excluding, the Centessa Special Mandatory Redemption Date |
| CUSIP / ISIN: | 532457 DK1 / US532457DK11 |
| **<u>The 2031 Notes</u>** |  |
| Principal Amount Offered: | $1500000000 |
| Maturity Date: | May 20, 2031 |
| Coupon: | 4.375% per year |
| Public Offering Price: | 99.893% of principal amount, plus accrued interest, if any, from May 20, 2026 |
| Yield to Maturity: | 4.399% |
| Benchmark Treasury: | UST 3.875% due April 30, 2031 |
| Spread to Benchmark Treasury: | T + 40 basis points |
| Benchmark Treasury Price and Yield: | 99-14 <sup>1</sup>⁄<sub>4</sub> / 3.999% |
| Interest Payment Dates: | May 20 and November 20 of each year, commencing November 20, 2026 |
| Redemption Provisions: |  |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Make-whole call: | At any time prior to April 20, 2031 at a discount rate of Treasury plus 10 basis points |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Par call: | On or after April 20, 2031 at 100% |

---

------

---

| | |
|:---|:---|
| Special Mandatory Redemption: | In the event that (x) the Centessa Acquisition is not consummated on or prior to the date that is five (5) business days after the later of (i) March 31, 2027 or (ii) any later date as the parties to the Centessa Agreement may agree as the "Outside Date" thereunder or (y) the Issuer notifies the trustee in writing that the Issuer will not pursue the consummation of the Centessa Acquisition, the Issuer will be required to redeem the 2031 Notes then outstanding at a redemption price equal to 101% of the principal amount of such 2031 Notes plus accrued and unpaid interest, if any, to, but excluding, the Centessa Special Mandatory Redemption Date |
| CUSIP / ISIN: | 532457 DL9 / US532457DL93 |
| **<u>The 2033 Notes</u>** |  |
| Principal Amount Offered: | $1250000000 |
| Maturity Date: | May 20, 2033 |
| Coupon: | 4.650% per year |
| Public Offering Price: | 99.982% of principal amount, plus accrued interest, if any, from May 20, 2026 |
| Yield to Maturity: | 4.653% |
| Benchmark Treasury: | UST 4.125% due April 30, 2033 |
| Spread to Benchmark Treasury: | T + 48 basis points |
| Benchmark Treasury Price and Yield: | 99-22 <sup>3</sup>⁄<sub>4</sub> / 4.173% |
| Interest Payment Dates: | May 20 and November 20 of each year, commencing November 20, 2026 |
| Redemption Provisions: |  |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Make-whole call: | At any time prior to March 20, 2033 at a discount rate of Treasury plus 10 basis points |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Par call: | On or after March 20, 2033 at 100% |
| Special Mandatory Redemption: | In the event that (x) the Centessa Acquisition is not consummated on or prior to the date that is five (5) business days after the later of (i) March 31, 2027 or (ii) any later date as the parties to the Centessa Agreement may agree as the "Outside Date" thereunder or (y) the Issuer notifies the trustee in writing that the Issuer will not pursue the consummation of the Centessa Acquisition, the Issuer will be required to redeem the 2033 Notes then outstanding at a redemption price equal to 101% of the principal amount of such 2033 Notes plus accrued and unpaid interest, if any, to, but excluding, the Centessa Special Mandatory Redemption Date |
| CUSIP / ISIN: | 532457 DM7 / US532457DM76 |

---

---

| | |
|:---|:---|
| **<u>The 2036 Notes</u>** |  |
| Principal Amount Offered: | $1500000000 |
| Maturity Date: | May 20, 2036 |
| Coupon: | 4.850% per year |
| Public Offering Price: | 99.640% of principal amount, plus accrued interest, if any, from May 20, 2026 |
| Yield to Maturity: | 4.896% |

---

------

---

| | |
|:---|:---|
| Benchmark Treasury: | UST 4.125% due February 15, 2036 |
| Spread to Benchmark Treasury: | T + 55 basis points |
| Benchmark Treasury Price and Yield: | 98-08 / 4.346% |
| Interest Payment Dates: | May 20 and November 20 of each year, commencing November 20, 2026 |
| Redemption Provisions: |  |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Make-whole call: | At any time prior to February 20, 2036 at a discount rate of Treasury plus 10 basis points |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Par call: | On or after February 20, 2036 at 100% |
| Special Mandatory Redemption: | In the event that (x) the Centessa Acquisition is not consummated on or prior to the date that is five (5) business days after the later of (i) March 31, 2027 or (ii) any later date as the parties to the Centessa Agreement may agree as the "Outside Date" thereunder or (y) the Issuer notifies the trustee in writing that the Issuer will not pursue the consummation of the Centessa Acquisition, the Issuer will be required to redeem the 2036 Notes then outstanding at a redemption price equal to 101% of the principal amount of such 2036 Notes plus accrued and unpaid interest, if any, to, but excluding, the Centessa Special Mandatory Redemption Date |
| CUSIP / ISIN: | 532457 DR6 / US532457DR63 |

---

---

| | |
|:---|:---|
| **<u>The 2056 Notes</u>** |  |
| Principal Amount Offered: | $1750000000 |
| Maturity Date: | May 20, 2056 |
| Coupon: | 5.600% per year |
| Public Offering Price: | 99.726% of principal amount, plus accrued interest, if any, from May 20, 2026 |
| Yield to Maturity: | 5.619% |
| Benchmark Treasury: | UST 4.625% due November 15, 2055 |
| Spread to Benchmark Treasury: | T + 68 basis points |
| Benchmark Treasury Price and Yield: | 95-04+ / 4.939% |
| Interest Payment Dates: | May 20 and November 20 of each year, commencing November 20, 2026 |
| Redemption Provisions: |  |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Make-whole call: | At any time prior to November 20, 2055 at a discount rate of Treasury plus 12.5 basis points |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Par call: | On or after November 20, 2055 at 100% |
| CUSIP / ISIN: | 532457 DP0 / US532457DP08 |

---

---

| | |
|:---|:---|
| **<u>The 2066 Notes</u>** |  |
| Principal Amount Offered: | $1000000000 |
| Maturity Date: | May 20, 2066 |
| Coupon: | 5.700% per year |
| Public Offering Price: | 99.391% of principal amount, plus accrued interest, if any, from May 20, 2026 |
| Yield to Maturity: | 5.739% |

---

------

---

| | |
|:---|:---|
| Benchmark Treasury: | UST 4.625% due November 15, 2055 |
| Spread to Benchmark Treasury: | T + 80 basis points |
| Benchmark Treasury Price and Yield: | 95-04+ / 4.939% |
| Interest Payment Dates: | May 20 and November 20 of each year, commencing November 20, 2026 |
| Redemption Provisions: |  |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Make-whole call: | At any time prior to November 20, 2065 at a discount rate of Treasury plus 15 basis points |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Par call: | On or after November 20, 2065 at 100% |
| CUSIP / ISIN: | 532457 DQ8 / US532457DQ80 |

---

\* A securities rating is not a recommendation to buy, sell or hold securities and may be subject to revision or withdrawal at any time.

\*\* Under Rule 15c6-1 under the Securities Exchange Act of 1934, as amended, trades in the secondary market are required to settle in one business day, unless the parties to any such trade expressly agree otherwise. Accordingly, purchasers who wish to trade the Notes prior to delivery will be required, by virtue of the fact that the Notes initially will settle in T+10, to specify an alternative settlement cycle at the time of any such trade to prevent failed settlement and should consult their own advisors. 

**The Issuer has filed a registration statement (No. 333-285052) (including a prospectus) with the Securities and Exchange Commission (the "SEC") for the offering to which this communication relates. Before you invest, you should read the prospectus in that registration statement, the preliminary prospectus relating to this offering and the other documents the Issuer has filed with the SEC for more complete information about the Issuer and this offering. You may get these documents for free by visiting EDGAR on the SEC's website at www.sec.gov. Alternatively, the Issuer, any underwriter or any dealer participating in the offering will arrange to send you the prospectus and the prospectus supplement if you request it by calling Morgan Stanley & Co. LLC at +1-866-718-1649, Citigroup Global Markets Inc. at +1-800-831-9146, Deutsche Bank Securities Inc. at +1-800-503-4611 or Goldman Sachs & Co. LLC at +1-866-471-2526.** 

*ANY DISCLAIMERS OR OTHER NOTICES THAT MAY APPEAR BELOW ARE NOT APPLICABLE TO THIS COMMUNICATION AND SHOULD BE DISREGARDED. SUCH DISCLAIMERS OR OTHER NOTICES WERE AUTOMATICALLY GENERATED AS A RESULT OF THIS COMMUNICATION BEING SENT VIA BLOOMBERG OR ANOTHER EMAIL SYSTEM.*